The impact of age on toxicity, response rate, quality of life, and survival in patients with advanced, Stage IIIB or IV nonsmall cell lung carcinoma treated with carboplatin and paclitaxel.

Download in:

• JSON
• RDF
• N3/Turtle
• N-Triples

View as

• Triples